Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis

NCT03047031 · clinicaltrials.gov ↗

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Nintedanib
DRUG: Pirfenidone

Sponsor

Boehringer Ingelheim